99 related articles for article (PubMed ID: 14575840)
1. Experimental application of boron neutron capture therapy to undifferentiated thyroid carcinoma.
Dagrosa MA; Viaggi M; Longhino J; Calzetta O; Cabrini R; Edreira M; Juvenal G; Pisarev MA
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1084-92. PubMed ID: 14575840
[TBL] [Abstract][Full Text] [Related]
2. Selective uptake of p-borophenylalanine by undifferentiated thyroid carcinoma for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Kreimann E; Farías S; Garavaglia R; Agote M; Cabrini RL; Dadino JL; Juvenal GJ; Pisarev MA
Thyroid; 2002 Jan; 12(1):7-12. PubMed ID: 11838734
[TBL] [Abstract][Full Text] [Related]
3. [Boron neutron capture therapy applied to undifferentiated thyroid carcinoma].
Pisarev MA; Dagrosa MA; Thomasz L; Juvenal G
Medicina (B Aires); 2006; 66(6):569-73. PubMed ID: 17240633
[TBL] [Abstract][Full Text] [Related]
4. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
[TBL] [Abstract][Full Text] [Related]
5. Boron neutron capture therapy in cancer: past, present and future.
Pisarev MA; Dagrosa MA; Juvenal GJ
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):852-6. PubMed ID: 17891250
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution of p-borophenylalanine (BPA) in dogs with spontaneous undifferentiated thyroid carcinoma (UTC).
Dagrosa MA; Viaggi M; Rebagliati RJ; Castillo VA; Batistoni D; Cabrini RL; Castiglia S; Juvenal GJ; Pisarev MA
Appl Radiat Isot; 2004 Nov; 61(5):911-5. PubMed ID: 15308167
[TBL] [Abstract][Full Text] [Related]
8. Boron neutron capture therapy for undifferentiated thyroid carcinoma: preliminary results with the combined use of BPA and BOPP.
Viaggi M; Dagrosa MA; Longhino J; Blaumann H; Calzetta O; Kahl SB; Juvenal GJ; Pisarev MA
Appl Radiat Isot; 2004 Nov; 61(5):905-9. PubMed ID: 15308166
[TBL] [Abstract][Full Text] [Related]
9. DNA damage induced by boron neutron capture therapy is partially repaired by DNA ligase IV.
Kondo N; Sakurai Y; Hirota Y; Tanaka H; Watanabe T; Nakagawa Y; Narabayashi M; Kinashi Y; Miyatake S; Hasegawa M; Suzuki M; Masunaga S; Ohnishi T; Ono K
Radiat Environ Biophys; 2016 Mar; 55(1):89-94. PubMed ID: 26573366
[TBL] [Abstract][Full Text] [Related]
10. In vitro studies of DNA damage and repair mechanisms induced by BNCT in a poorly differentiated thyroid carcinoma cell line.
Rodriguez C; Carpano M; Curotto P; Thorp S; Casal M; Juvenal G; Pisarev M; Dagrosa MA
Radiat Environ Biophys; 2018 May; 57(2):143-152. PubMed ID: 29453554
[TBL] [Abstract][Full Text] [Related]
11. Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy.
Ono K; Masunaga SI; Kinashi Y; Takagaki M; Akaboshi M; Kobayashi T; Akuta K
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1081-6. PubMed ID: 8600091
[TBL] [Abstract][Full Text] [Related]
12. Experimental studies of boron neutron capture therapy (BNCT) using histone deacetylase inhibitor (HDACI) sodium butyrate, as a complementary drug for the treatment of poorly differentiated thyroid cancer (PDTC).
Perona M; Majdalani ME; Rodríguez C; Nievas S; Carpano M; Rossini A; Longhino JM; Cabrini R; Pisarev MA; Juvenal GJ; Dagrosa MA
Appl Radiat Isot; 2020 Oct; 164():109297. PubMed ID: 32768887
[TBL] [Abstract][Full Text] [Related]
13. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
14. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.
Kamida A; Obayashi S; Kato I; Ono K; Suzuki M; Nagata K; Sakurai Y; Yura Y
Int J Radiat Biol; 2006 Jan; 82(1):21-9. PubMed ID: 16546900
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of the high-LET radiations from the boron neutron capture [10B(n,α) 7Li] reaction determined for induction of chromosome aberrations and apoptosis in lymphocytes of human blood samples.
Schmid TE; Canella L; Kudejova P; Wagner FM; Röhrmoser A; Schmid E
Radiat Environ Biophys; 2015 Mar; 54(1):91-102. PubMed ID: 25428113
[TBL] [Abstract][Full Text] [Related]
16. Studies for the application of boron neutron capture therapy to the treatment of differentiated thyroid cancer.
Dagrosa A; Carpano M; Perona M; Thomasz L; Nievas S; Cabrini R; Juvenal G; Pisarev M
Appl Radiat Isot; 2011 Dec; 69(12):1752-5. PubMed ID: 21570311
[TBL] [Abstract][Full Text] [Related]
17. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
[TBL] [Abstract][Full Text] [Related]
18. Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors.
Barth RF; Grecula JC; Yang W; Rotaru JH; Nawrocky M; Gupta N; Albertson BJ; Ferketich AK; Moeschberger ML; Coderre JA; Rofstad EK
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):267-77. PubMed ID: 14697448
[TBL] [Abstract][Full Text] [Related]
19. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
